Cell line · CVCL_1685
SCC-9
Cancer cell line, Homo sapiens. Tongue squamous cell carcinoma. 63 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SCC-9. Cell lines, record CVCL_1685. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1685
On this page
Cell line
As Cellosaurus gives it.
- Name
- SCC-9
- Accession
- CVCL_1685
- RRID
- RRID:CVCL_1685
- Synonyms
- SCC 9, SCC9, SFCI-SCC-09
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 25Y
- Category
- Cancer cell line
- Diseases
- Tongue squamous cell carcinoma (NCIt C4648); Squamous cell carcinoma of the oral tongue (ORDO Orphanet_457252)
- Derived from
- Oral cavity, tongue, anterior part (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | TP53 mutation indicated incorrectly as being at p.Val274_Glu285del (c.820_851del32) in PubMed=1423286 and PubMed=25275298. |
Source Cellosaurus
Papers63
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Capsaicin suppresses metastasis in tongue squamous cell carcinoma by reversing epithelial-mesenchymal transition via the AMPK/HIF-1α/Claudin-1 axis | Biol Direct | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma. | Int J Oral Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma. | Cell Death Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Isoform-specific cofactor recruitment through the intrinsically disordered N-terminus of p63 underlies differential transcriptional activities. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TNFRSF10B, a Therapeutic Target for Oral Squamous Cell Carcinoma Through Integrated Bioinformatics and Preliminary Experiments. | Technol Cancer Res Treat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| pH/ROS-Responsive Injectable Hydrogel Co-Loaded with B7-H3 Blocker and NETs Suppressor Boosts OSCC Synergistic Immunotherapy. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Interplay of YEATS2 and GCDH regulates histone crotonylation and drives EMT in head and neck cancer. | Elife | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Blocking YAP1-Liprin-β2 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 63
See all 63 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | SCC9 fat-1 | CVCL_E6ZH | Cell lines | |
| Derived from it | SFCI-SCC-09ko | CVCL_E7HC | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1629 | ATCC | |
| BCRJ | 0196 | BCRJ | |
| CLS | 305390 | CLS | |
| ECACC | 89062003 | ECACC | |
| RCB | RCB0718 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1685
GET https://conductscience.org/api/cell-lines/v1/CVCL_1685/papers?page=2